| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $363.0M | +185.0% |
| Cost of Revenue | $329.9M | +161.6% |
| Gross Profit | $33.1M | +2553.7% |
| R&D Expense | $38.3M | +68.6% |
| SG&A Expense | $77.0M | +85.0% |
| Operating Income | -$131.1M | -57.8% |
| Interest Expense | $10.5M | -39.8% |
| Pre-tax Income | -$139.2M | -37.5% |
| Income Tax | -$15.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.9M | -88.2% |
| Short-term Investments | $162.1M | -6.3% |
| Accounts Receivable | $223.2M | +261.8% |
| Inventory | $8.4M | -63.1% |
| Current Assets | $532.8M | -48.0% |
| Total Assets | $1.42B | +19.3% |
| Current Liabilities | $267.0M | +203.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$106.0M | -4.7% |
| Investing Cash Flow | -$544.4M | -193.9% |
| Financing Cash Flow | -$9.3M | -100.9% |
| — |
| Net Income | -$124.1M | -22.6% |
| EPS (Basic) | -$0.81 | +15.6% |
| EPS (Diluted) | -$0.81 | +15.6% |
| Total Liabilities |
| $869.7M |
| +66.0% |
| Stockholders' Equity | $551.6M | -17.4% |